Thinly traded penny stock ImmunoCellular Therapeutics (OTCPK:IMUC +37.1%) is up on a 10x surge in volume in response to its announcement that an unnamed private biotech has agreed to purchase its …

More ImmunoCellular up 37% on asset sale Videos